PortfoliosLab logo
EXAS vs. IDXX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EXAS and IDXX is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

EXAS vs. IDXX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Exact Sciences Corporation (EXAS) and IDEXX Laboratories, Inc. (IDXX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

EXAS:

0.15

IDXX:

-0.13

Sortino Ratio

EXAS:

0.56

IDXX:

0.22

Omega Ratio

EXAS:

1.08

IDXX:

1.03

Calmar Ratio

EXAS:

0.06

IDXX:

-0.01

Martin Ratio

EXAS:

0.20

IDXX:

-0.03

Ulcer Index

EXAS:

22.45%

IDXX:

17.75%

Daily Std Dev

EXAS:

58.98%

IDXX:

31.96%

Max Drawdown

EXAS:

-98.01%

IDXX:

-81.46%

Current Drawdown

EXAS:

-63.60%

IDXX:

-26.59%

Fundamentals

Market Cap

EXAS:

$10.64B

IDXX:

$41.67B

EPS

EXAS:

-$5.55

IDXX:

$10.80

PEG Ratio

EXAS:

-1.07

IDXX:

4.23

PS Ratio

EXAS:

3.76

IDXX:

10.60

PB Ratio

EXAS:

4.42

IDXX:

28.44

Total Revenue (TTM)

EXAS:

$2.83B

IDXX:

$3.93B

Gross Profit (TTM)

EXAS:

$1.93B

IDXX:

$2.41B

EBITDA (TTM)

EXAS:

-$848.74M

IDXX:

$1.29B

Returns By Period

In the year-to-date period, EXAS achieves a 0.41% return, which is significantly lower than IDXX's 25.31% return. Over the past 10 years, EXAS has underperformed IDXX with an annualized return of 7.84%, while IDXX has yielded a comparatively higher 22.48% annualized return.


EXAS

YTD

0.41%

1M

35.69%

6M

14.37%

1Y

11.99%

5Y*

-7.63%

10Y*

7.84%

IDXX

YTD

25.31%

1M

25.91%

6M

23.09%

1Y

-4.66%

5Y*

11.89%

10Y*

22.48%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EXAS vs. IDXX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EXAS
The Risk-Adjusted Performance Rank of EXAS is 5454
Overall Rank
The Sharpe Ratio Rank of EXAS is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of EXAS is 5353
Sortino Ratio Rank
The Omega Ratio Rank of EXAS is 5353
Omega Ratio Rank
The Calmar Ratio Rank of EXAS is 5454
Calmar Ratio Rank
The Martin Ratio Rank of EXAS is 5353
Martin Ratio Rank

IDXX
The Risk-Adjusted Performance Rank of IDXX is 4545
Overall Rank
The Sharpe Ratio Rank of IDXX is 4444
Sharpe Ratio Rank
The Sortino Ratio Rank of IDXX is 4141
Sortino Ratio Rank
The Omega Ratio Rank of IDXX is 4242
Omega Ratio Rank
The Calmar Ratio Rank of IDXX is 5050
Calmar Ratio Rank
The Martin Ratio Rank of IDXX is 4949
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EXAS vs. IDXX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Exact Sciences Corporation (EXAS) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current EXAS Sharpe Ratio is 0.15, which is higher than the IDXX Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of EXAS and IDXX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

EXAS vs. IDXX - Dividend Comparison

Neither EXAS nor IDXX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

EXAS vs. IDXX - Drawdown Comparison

The maximum EXAS drawdown since its inception was -98.01%, which is greater than IDXX's maximum drawdown of -81.46%. Use the drawdown chart below to compare losses from any high point for EXAS and IDXX. For additional features, visit the drawdowns tool.


Loading data...

Volatility

EXAS vs. IDXX - Volatility Comparison

Exact Sciences Corporation (EXAS) has a higher volatility of 11.88% compared to IDEXX Laboratories, Inc. (IDXX) at 10.26%. This indicates that EXAS's price experiences larger fluctuations and is considered to be riskier than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

EXAS vs. IDXX - Financials Comparison

This section allows you to compare key financial metrics between Exact Sciences Corporation and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00B20212022202320242025
706.79M
998.43M
(EXAS) Total Revenue
(IDXX) Total Revenue
Values in USD except per share items

EXAS vs. IDXX - Profitability Comparison

The chart below illustrates the profitability comparison between Exact Sciences Corporation and IDEXX Laboratories, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
70.8%
62.4%
(EXAS) Gross Margin
(IDXX) Gross Margin
EXAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a gross profit of 500.55M and revenue of 706.79M. Therefore, the gross margin over that period was 70.8%.

IDXX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported a gross profit of 623.38M and revenue of 998.43M. Therefore, the gross margin over that period was 62.4%.

EXAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported an operating income of -96.01M and revenue of 706.79M, resulting in an operating margin of -13.6%.

IDXX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported an operating income of 316.53M and revenue of 998.43M, resulting in an operating margin of 31.7%.

EXAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a net income of -101.22M and revenue of 706.79M, resulting in a net margin of -14.3%.

IDXX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported a net income of 242.68M and revenue of 998.43M, resulting in a net margin of 24.3%.